WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 3701 Infant (under 12 months) mortality rate: 582
GDP / capita (US$): 6551 Child (under 5 years) mortality rate: 782

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 4'190  4'080  3'958  3'821  3'673  2'892  2'103  1'893 
Births 150  148  146  143  141  119  95  93 
Surviving infants 141  139  136  134  131  105  80  79 
Pop. less than 5 years 678  668  655  641  621  496  371  348 
Pop. less than 15 years 1'806  1'764  1'716  1'661  1'597  1'250  948  850 
Female 15-49 years 976  948  919  887  853  676  473  428 

Number of reported case

(Click for retrospective incidence data for Liberia)
Diphtheria
Japanese encephalitis
Measles 43  279  2'200  5'977  6'567 
Mumps
Pertussis 281  62 
Polio* 11  98 
Rubella 39  30  40 
Rubella (CRS)
Tetanus (neonatal) 12  152  207 
Tetanus (total) 12  228  307 
Yellow fever 17  137 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Liberia)
Vaccine year result method % card seen                                                
BCG 2011  94     77.1  85  85  76  92  92  45 
DTP1 2011  92     77.1  99*  86  85  100  99* 
DTP3 2011  77     77.1  93  77  75  92  92  48 
HepB_BD         
HepB3 2011  77     77.1  93  77  75  93  92 
Hib3 2011  77     77.1  93  77  75  93  92 
JapEnc         
MCV 2011  62     77.1  80  71  72  95  95  52 
MCV2         
PCV1         
PCV3         
Pol3 2011  76     77.1  93  77  60  92  92  52 
Rota1         
Rota_last         
Rubella1         
TT2plus 1994  77  MICS     74  74  63  90  90  25 
PAB         
VAD1          43  56  63  73  73  26 
YFV 2011  61     77.1  78  70  71  95  93 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Liberia)
BCG 85  85  73  87  85  78 
DTP1 86  86  80  90  85  80 
DTP3 77  77  70  81  75  46 
HepB3 77  77  47  64  64 
Hib3 77  77  47  64  64 
MCV 80  71  65  83  76  63 
PAB 91  91  91  91  91  51  33 
PCV3
Pol3 77  77  71  84  79  56 
Rota_last
YFV 78  70  64  83  74 

Number of districts in the country 15  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 47
From 80 to 89% 47
From 50 to 79% 7
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes From October 2013
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 15  15  15  15  15  15 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 15  15  15  15  15  15  15 
Nº districts with DTP3 coverage >=80% number 14  13  14  10  10 
% of districts with DTP3 coverage >=80% From 0 to 100% 93  53  47  87  93  67  67 
Nº districts with measles (MCV1) coverage >=95% number 10  12     
% of districts with MCV1 coverage >=95% From 0 to 100% 13  13  67  80     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  No    Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 91   

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.